133 related articles for article (PubMed ID: 10551006)
1. Adenosine and P2 receptors in PC12 cells. Genotypic, phenotypic and individual differences.
Arslan G; Fredholm BB
Prog Brain Res; 1999; 120():301-10. PubMed ID: 10551006
[No Abstract] [Full Text] [Related]
2. P2 purinoceptor-mediated stimulation of adenylyl cyclase in PC12 cells.
Yakushi Y; Watanabe A; Murayama T; Nomura Y
Eur J Pharmacol; 1996 Oct; 314(1-2):243-8. PubMed ID: 8957242
[TBL] [Abstract][Full Text] [Related]
3. Adenosine and ATP: progress in their receptors' structures and functions.
Khakh BS; Kennedy C
Trends Pharmacol Sci; 1998 Feb; 19(2):39-41. PubMed ID: 9550938
[No Abstract] [Full Text] [Related]
4. Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions.
Apasov S; Koshiba M; Redegeld F; Sitkovsky MV
Immunol Rev; 1995 Aug; 146():5-19. PubMed ID: 7493760
[No Abstract] [Full Text] [Related]
5. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
Neary JT; McCarthy M; Kang Y; Zuniga S
Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
[TBL] [Abstract][Full Text] [Related]
6. A2A adenosine receptors inhibit ATP-induced Ca2+ influx in PC12 cells by involving protein kinase A.
Park TJ; Song SK; Kim KT
J Neurochem; 1997 May; 68(5):2177-85. PubMed ID: 9109546
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function.
Roman RM; Fitz JG
Gastroenterology; 1999 Apr; 116(4):964-79. PubMed ID: 10092320
[No Abstract] [Full Text] [Related]
8. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
[TBL] [Abstract][Full Text] [Related]
9. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release.
Koolpe M; Pearson D; Benton HP
Arthritis Rheum; 1999 Feb; 42(2):258-67. PubMed ID: 10025919
[TBL] [Abstract][Full Text] [Related]
10. Purines and neutrophil leukocytes.
Fredholm BB
Gen Pharmacol; 1997 Mar; 28(3):345-50. PubMed ID: 9068971
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of atrial contraction by P1 and P2 purinoceptors in normotensive and spontaneously hypertensive rats.
Rodrigues JQ; da Silva ED; de Magalhães Galvão K; Miranda-Ferreira R; Caricati-Neto A; Jurkiewicz NH; Garcia AG; Jurkiewicz A
Hypertens Res; 2014 Mar; 37(3):210-9. PubMed ID: 24285249
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine.
Inbe H; Watanabe S; Miyawaki M; Tanabe E; Encinas JA
J Biol Chem; 2004 May; 279(19):19790-9. PubMed ID: 15001573
[TBL] [Abstract][Full Text] [Related]
13. Heteromeric association creates a P2Y-like adenosine receptor.
Yoshioka K; Saitoh O; Nakata H
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7617-22. PubMed ID: 11390975
[TBL] [Abstract][Full Text] [Related]
14. Signaling by extracellular nucleotides and nucleosides.
Illes P; Klotz KN; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):295-8. PubMed ID: 11111824
[No Abstract] [Full Text] [Related]
15. P2Y(11), a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells.
Nguyen TD; Meichle S; Kim US; Wong T; Moody MW
Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G795-804. PubMed ID: 11292586
[TBL] [Abstract][Full Text] [Related]
16. Adenosine and ATP: from receptor structure to clinical applications.
Kennedy C; IJzerman A
Trends Pharmacol Sci; 1994 Sep; 15(9):311-2. PubMed ID: 7992379
[No Abstract] [Full Text] [Related]
17. Purinergic signalling: pathophysiological roles.
Abbracchio MP; Burnstock G
Jpn J Pharmacol; 1998 Oct; 78(2):113-45. PubMed ID: 9829617
[TBL] [Abstract][Full Text] [Related]
18. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
Chang YH; Conti M; Lee YC; Lai HL; Ching YH; Chern Y
J Neurochem; 1997 Sep; 69(3):1300-9. PubMed ID: 9282956
[TBL] [Abstract][Full Text] [Related]
19. The past, present and future of purine nucleotides as signalling molecules.
Burnstock G
Neuropharmacology; 1997 Sep; 36(9):1127-39. PubMed ID: 9364468
[No Abstract] [Full Text] [Related]
20. P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells.
Arslan G; Filipeanu CM; Irenius E; Kull B; Clementi E; Allgaier C; Erlinge D; Fredholm BB
Neuropharmacology; 2000 Jan; 39(3):482-96. PubMed ID: 10698014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
